Edgar Filing: MARKETAXESS HOLDINGS INC

MARKETAXESS HOLDINGS INC.

Date: March 1, 2013

/s/ Richard M. McVey

Name: Richard M. McVey

Title: Chief Executive Officer

Form 8-K

OMB APPROVAL

OMB Number: 3235-0060

Expires: February 28, 2013

Estimated average burden

hours per response........5.68

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 27, 2013

MarketAxess Holdings Inc.

(Exact name of registrant as specified in its charter)


Delaware	001-34091	52-2230784
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

299 Park Avenue New York, New York		10171
(Address of principal executive offices)		(Zip Code)

(212) 813-6000

Registrant’s telephone number, including area code

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Departure of Directors or Certain Officers

On February 27, 2013, Dr. Sharon Brown-Hruska informed the board of directors (the “Board”) of MarketAxess Holdings Inc. (the “Company”) that she does not intend to stand for re-election to the Board when her current term ends at the Company’s 2013 annual meeting of stockholders.

Dr. Brown-Hruska has been a director since April 2010. Dr. Brown-Hruska’s decision not to stand for re-election to the Board does not involve any disagreement with the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.